Antibodies specific for Hu-B1.219, a novel hematopoietin receptor
US6005080A · kind A · utility
12Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1996 |
| Grant date | Dec 21, 1999 |
| Priority date | — |
| Expiry date | Aug 5, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a novel member of the hematopoietin receptor family, herein referred to as Hu-B1.219. In particular, the invention relates to nucleotide sequences and expression vectors encoding Hu-B1.219 gene product. Genetically engineered host cells that express the Hu-B1.219 coding sequence may be used to evaluate and screen for ligands or drugs involved in Hu-B1.219 interaction and regulation. Since Hu-B1.219 expression has been detected in certain human fetal tissues and cancer cells, molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.